Hypoxia Bone Marrow Mesenchymal Stem Cell-derived Exosomal AHCY Facilitates the Development of Lung Cancer via MCCC2-activated ERK Pathway

Bing Han, Feifei Ma, Junhua Hu, Zhenzhen Zheng, Chao Su, Xinnan Song

PDF(13233 KB)
For Authors|For Editors|For Reviewers
PDF(13233 KB)
Discovery Medicine ›› 2026, Vol. 38 ›› Issue (208) : 1635-1648. DOI: 10.24976/Discov.Med.202638208.128
Article

Hypoxia Bone Marrow Mesenchymal Stem Cell-derived Exosomal AHCY Facilitates the Development of Lung Cancer via MCCC2-activated ERK Pathway

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 38(208): 1635-1648 https://doi.org/10.24976/Discov.Med.202638208.128

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(13233 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2026.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉